Gut microbiota-dependent metabolite Trimethylamine N-oxide contributes to cardiac dysfunction in western diet-induced obese mice

Frontiers in Physiology

Volumn 8, Issue MAR, 2017, Pages

  Chen, Kui ^a   Zheng, Xiaoqian ^a   Feng, Mingchen ^a   Li, Dongliang ^b   Zhang, Hongqi ^a  

^a JINING NO 1 PEOPLE S HOSPITAL   (China)

^b SHANDONG UNIVERSITY   (China)

Author keywords

Cardiac function; Fibrosis; Inflammation; Trimethylamine N oxide; Western diet

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 1BETA; TRIMETHYLAMINE OXIDE; TUMOR NECROSIS FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; CARDITIS; CONTROLLED STUDY; DYSLIPIDEMIA; ECHOCARDIOGRAPHY; FIBROSING ALVEOLITIS; HEART DISEASE; HEART MUSCLE FIBROSIS; INTESTINE FLORA; MALE; MOUSE; NONHUMAN; OBESITY; PATHOGENESIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; WESTERN DIET;

EID: 85016146864     PISSN: None     EISSN: 1664042X     Source Type: Journal    
DOI: 10.3389/fphys.2017.00139     Document Type: Article

References (37)

1. Bäckhed, F., Ding, H., Wang, T., Hooper, L. V., Koh, G. Y., Nagy, A., et al. (2004). The gut microbiota as an environmental factor that regulates fat storage. Proc. Natl. Acad. Sci. U.S.A. 101, 15718-15723. doi: 10.1073/pnas.0407076101
2. Baena-Díez, J. M., Byram, A. O., Grau, M., Gómez-Fernández, C., Vidal-Solsona, M., Ledesma-Ulloa, G., et al. (2010). Obesity is an independent risk factor for heart failure: Zona Franca Cohort study. Clin. Cardiol. 33, 760-764. doi: 10.1002/clc.20837
3. Boutagy, N. E., Neilson, A. P., Osterberg, K. L., Smithson, A. T., Englund, T. R., Davy, B. M., et al. (2015a). Probiotic supplementation and trimethylamine-N-oxide production following a high-fat diet. Obesity 23, 2357-2363. doi: 10.1002/oby.21212
4. Boutagy, N. E., Neilson, A. P., Osterberg, K. L., Smithson, A. T., Englund, T. R., Davy, B. M., et al. (2015b). Short-term high-fat diet increases postprandial trimethylamine-N-oxide in humans. Nutr. Res. 35, 858-864. doi: 10.1016/j.nutres.2015.07.002
5. Brown, J. M., and Hazen, S. L. (2015). The gut microbial endocrine organ: bacterially derived signals driving cardiometabolic diseases. Annu. Rev. Med. 66, 343-359. doi: 10.1146/annurev-med-060513-093205
6. Carbone, S., Mauro, A. G., Mezzaroma, E., Kraskauskas, D., Marchetti, C., Buzzetti, R., et al. (2015). A high-sugar and high-fat diet impairs cardiac systolic and diastolic function in mice. Int. J. Cardiol. 198, 66-69. doi: 10.1016/j.ijcard.2015.06.136
7. Chang, C. J., Lin, C. S., Lu, C. C., Martel, J., Ko, Y. F., Ojcius, D. M., et al. (2015). Ganoderma lucidum reduces obesity in mice by modulating the composition of the gut microbiota. Nat. Commun. 6:7489. doi: 10.1038/ncomms8489
8. Chen, M. L., Yi, L., Zhang, Y., Zhou, X., Ran, L., Yang, J., et al. (2016). Resveratrol Attenuates Trimethylamine-N-Oxide (TMAO)-Induced Atherosclerosis by regulating TMAO synthesis and Bile acid metabolism via remodeling of the gut microbiota. MBio 7, e02210-e02215. doi: 10.1128/mBio.02210-15
9. David, L. A., Maurice, C. F., Carmody, R. N., Gootenberg, D. B., Button, J. E., Wolfe, B. E., et al. (2014). Diet rapidly and reproducibly alters the human gut microbiome. Nature 505, 559-563. doi: 10.1038/nature12820
10. Flegal, K. M., Carroll, M. D., Kit, B. K., and Ogden, C. L. (2012). Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999-2010. JAMA 307, 491-497. doi: 10.1001/jama.2012.39
11. Foote, C. A., Castorena-Gonzalez, J. A., Ramirez-Perez, F. I., Jia, G., Hill, M. A., Reyes-Aldasoro, C. C., et al. (2016). Arterial stiffening in western diet-fed mice is associated with increased vascular elastin, transforming growth factor-beta, and plasma neuraminidase. Front. Physiol. 7:285. doi: 10.3389/fphys.2016.00285
12. Grant, L., Shearer, K. D., Czopek, A., Lees, E. K., Owen, C., Agouni, A., et al. (2014). Myeloid-cell protein tyrosine phosphatase-1B deficiency in mice protects against high-fat diet and lipopolysaccharide-induced inflammation, hyperinsulinemia, and endotoxemia through an IL-10 STAT3-dependent mechanism. Diabetes 63, 456-470. doi: 10.2337/db13-0885
13. Gustafsson, F., Kragelund, C. B., Torp-Pedersen, C., Seibaek, M., Burchardt, H., Akkan, D., et al. (2005). Effect of obesity and being overweight on long-term mortality in congestive heart failure: influence of left ventricular systolic function. Eur. Heart J. 26, 58-64. doi: 10.1093/eurheartj/ehi022
14. Head, G. A. (2015). Cardiovascular and metabolic consequences of obesity. Front. Physiol. 6:32. doi: 10.3389/fphys.2015.00032
15. Hildebrandt, M. A., Hoffmann, C., Sherrill-Mix, S. A., Keilbaugh, S. A., Hamady, M., Chen, Y. Y., et al. (2009). High-fat diet determines the composition of the murine gut microbiome independently of obesity. Gastroenterology 137, 1716-1724 e1711-e1712. doi: 10.1053/j.gastro.2009.08.042
16. Kenchaiah, S., Evans, J. C., Levy, D., Wilson, P. W., Benjamin, E. J., Larson, M. G., et al. (2002). Obesity and the risk of heart failure. N. Engl. J. Med. 347, 305-313. doi: 10.1056/NEJMoa020245
17. Kesherwani, V., Chavali, V., Hackfort, B. T., Tyagi, S. C., and Mishra, P. K. (2015). Exercise ameliorates high fat diet induced cardiac dysfunction by increasing interleukin 10. Front. Physiol. 6:124. doi: 10.3389/fphys.2015.00124
18. Kitai, T., Kirsop, J., and Tang, W. H. (2016). Exploring the microbiome in heart failure. Curr. Heart Fail. Rep. 13, 103-109. doi: 10.1007/s11897-016-0285-9
19. Organ, C. L., Otsuka, H., Bhushan, S., Wang, Z., Bradley, J., Trivedi, R., et al. (2016). Choline diet and its gut microbe-derived metabolite, trimethylamine N-Oxide, exacerbate pressure overload-induced heart failure. Circ. Heart Fail. 9:e002314. doi: 10.1161/CIRCHEARTFAILURE.115.002314
20. Prospective Studies, C., Whitlock, G., Lewington, S., Sherliker, P., Clarke, R., Emberson, J., et al. (2009). Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies. Lancet 373, 1083-1096. doi: 10.1016/S0140-6736(09)60318-4
21. Sahoo, K., Sahoo, B., Choudhury, A. K., Sofi, N. Y., Kumar, R., and Bhadoria, A. S. (2015). Childhood obesity: causes and consequences. J. Family Med. Prim. Care 4, 187-192. doi: 10.4103/2249-4863.154628
22. Seldin, M. M., Meng, Y., Qi, H., Zhu, W., Wang, Z., Hazen, S. L., et al. (2016). Trimethylamine N-Oxide promotes vascular inflammation through signaling of mitogen-activated protein kinase and nuclear factor-κB. J. Am. Heart Assoc. 5:e002767. doi: 10.1161/JAHA.115.002767
23. Senthong, V., Wang, Z., Fan, Y., Wu, Y., Hazen, S. L., and Tang, W. H. (2016). Trimethylamine N-Oxide and mortality risk in patients with peripheral artery disease. J. Am. Heart Assoc. 5:e004237. doi: 10.1161/JAHA.116.004237
24. Soliman, H., Nyamandi, V., Garcia-Patino, M., Varela, J. N., Bankar, G., Lin, G., et al. (2015). Partial deletion of ROCK2 protects mice from high-fat diet-induced cardiac insulin resistance and contractile dysfunction. Am. J. Physiol. Heart Circ. Physiol. 309, H70-H81. doi: 10.1152/ajpheart.00664.2014
25. Sun, M., Chen, M., Dawood, F., Zurawska, U., Li, J. Y., Parker, T., et al. (2007). Tumor necrosis factor-alpha mediates cardiac remodeling and ventricular dysfunction after pressure overload state. Circulation 115, 1398-1407. doi: 10.1161/CIRCULATIONAHA.106.643585
26. Tang, W. H., and Hazen, S. L. (2014). The contributory role of gut microbiota in cardiovascular disease. J. Clin. Invest. 124, 4204-4211. doi: 10.1172/JCI72331
27. Tang, W. H., and Hazen, S. L. (2017). Microbiome, trimethylamine N-oxide, and cardiometabolic disease. Transl. Res. 179, 108-115. doi: 10.1016/j.trsl.2016.07.007
28. Tang, W. H., Wang, Z., Fan, Y., Levison, B., Hazen, J. E., Donahue, L. M., et al. (2014). Prognostic value of elevated levels of intestinal microbe-generated metabolite trimethylamine-N-oxide in patients with heart failure: refining the gut hypothesis. J. Am. Coll. Cardiol. 64, 1908-1914. doi: 10.1016/j.jacc.2014.02.617
29. Tang, W. H., Wang, Z., Kennedy, D. J., Wu, Y., Buffa, J. A., Agatisa-Boyle, B., et al. (2015a). Gut microbiota-dependent trimethylamine N-oxide (TMAO) pathway contributes to both development of renal insufficiency and mortality risk in chronic kidney disease. Circ. Res. 116, 448-455. doi: 10.1161/CIRCRESAHA.116.305360
30. Tang, W. H., Wang, Z., Levison, B. S., Koeth, R. A., Britt, E. B., Fu, X., et al. (2013). Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk. N. Engl. J. Med. 368, 1575-1584. doi: 10.1056/NEJMoa1109400
31. Tang, W. H., Wang, Z., Shrestha, K., Borowski, A. G., Wu, Y., Troughton, R. W., et al. (2015b). Intestinal microbiota-dependent phosphatidylcholine metabolites, diastolic dysfunction, and adverse clinical outcomes in chronic systolic heart failure. J. Card. Fail. 21, 91-96. doi: 10.1016/j.cardfail.2014.11.006
32. Turnbaugh, P. J., Bäckhed, F., Fulton, L., and Gordon, J. I. (2008). Diet-induced obesity is linked to marked but reversible alterations in the mouse distal gut microbiome. Cell Host Microbe 3, 213-223. doi: 10.1016/j.chom.2008.02.015
33. Ufnal, M., Jazwiec, R., Dadlez, M., Drapala, A., Sikora, M., and Skrzypecki, J. (2014). Trimethylamine-N-oxide: a carnitine-derived metabolite that prolongs the hypertensive effect of angiotensin II in rats. Can. J. Cardiol. 30, 1700-1705. doi: 10.1016/j.cjca.2014.09.010
34. Wang, Y., Li, Y., Wu, Y., Jia, L., Wang, J., Xie, B., et al. (2014). 5TNF-alpha and IL-1beta neutralization ameliorates angiotensin II-induced cardiac damage in male mice. Endocrinology 155, 2677-2687. doi: 10.1210/en.2013-2065
35. Wang, Z., Klipfell, E., Bennett, B. J., Koeth, R., Levison, B. S., Dugar, B., et al. (2011). Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease. Nature 472, 57-63. doi: 10.1038/nature09922
36. Wang, Z., Roberts, A. B., Buffa, J. A., Levison, B. S., Zhu, W., Org, E., et al. (2015). Non-lethal inhibition of gut microbial trimethylamine production for the treatment of atherosclerosis. Cell 163, 1585-1595. doi: 10.1016/j.cell.2015.11.055
37. Wang, Z., Tang, W. H., Buffa, J. A., Fu, X., Britt, E. B., Koeth, R. A., et al. (2014). Prognostic value of choline and betaine depends on intestinal microbiota-generated metabolite trimethylamine-N-oxide. Eur. Heart J. 35, 904-910. doi: 10.1093/eurheartj/ehu002